Moderna announces single-dose booster shot for protection against COVID-19, flu
Moderna announced Thursday a series of new projects, including the development of a booster shot that would provide additional protection against COVID-19 and the flu in a single dose.
Posted — UpdatedModerna announced Thursday a series of new projects, including the development of a booster shot that would provide additional protection against COVID-19 and the flu in a single dose.
A timelime for the development, research and release of the booster was not announced.
CEO Stéphane Bancel announced the news on Twitter, calling it the first step in Moderna's novel respiratory vaccine program.
To date, booster shots are only recommended for people with autoimmune disorders and those at greater risk for becoming severely ill from COVID-19. If the booster is recommended for all vaccinated individuals, people should get the third dose, which is identical to the first two doses, eight months after receiving their second dose.
FDA scientific advisers will publicly debate Pfizer's evidence of the protection of a booster on Sept. 17. If the FDA approves another dose, then advisers to the Centers for Disease Control and Prevention will recommend who should get one. The process to approve Moderna's booster vaccine may take longer, especially since Moderna has stated it wants its booster to be half the dose of the original shots.
Related Topics
• Credits
Copyright 2024 by Capitol Broadcasting Company. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.